Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Dr Lalchandani Labs Ltd

Your Vote -

Buy

25.00%

Hold

25.00%

Sell

50.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Dr Lalchandani Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dr. Lalchandani Labs - Board Meeting Outcome for Approval Of Audited Financial Statement For Half Year And Year Ended March 3

    3 Jun 2026, 9:38PM Audited Financial Results for the quarter and year ended March 31, 2026
  • Dr. Lalchandani Labs - Approval Of Audited Financial Results For The Half Year And Year Ended March 31, 2026

    3 Jun 2026, 9:27PM Audited Financial Results for the half year and year ended March 31, 2206
  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Meeting Updates

    30 May 2026, 7:30PM Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30, 2026.
  • Dr. Lalchandani Labs - Opening Of New Centre At Dwarka Delhi

    28 May 2026, 6:14PM We are pleased to inform that the Company has successfully opened a new strategic Centre at Dwarka New Delhi.
  • Dr. Lalchandani Labs - Board Meeting Intimation for Consideration And Approval Of Financial Results Of The Company For Half Y

    27 May 2026, 6:02PM Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider
  • Dr. Lalchandani Labs - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    4 May 2026, 12:49PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • Dr. Lalchandani Labs - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    30 Apr 2026, 1:51PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    22 Apr 2026, 4:36PM Resignation of Mrs. Saniya Hussain from the position of Company Secretary and Compliance Officer
  • Dr. Lalchandani Labs - Reply To The Clarification Sought By BSE

    13 Apr 2026, 7:45PM Reply to the clarification sought by exchange dated April 13, 2026
  • Dr. Lalchandani Labs - Clarification sought from Dr Lalchandani Labs Ltd

    13 Apr 2026, 7:30PM The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 13, 2026 with reference to significant movement in price, in order to ensu
  • Dr. Lalchandani Labs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    10 Apr 2026, 11:21AM As of March 2026, 32.90% is owned by Indian Promoters and 67.10% by Public. <p align=justify> Top three Promoters holding highest number of shares of
  • Dr. Lalchandani Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2026, 6:56PM Certificate under Regulation 74(5) of SEBI DP Regulations for Quarter ended March 2026
  • Dr. Lalchandani Labs has submitted to BSE the Shareholding Pattern for the Period Ended March 02, 2026

    10 Mar 2026, 8:30PM As of March 2026, 32.90% is owned by Indian Promoters and 67.10% by Public. <p align=justify> Top three Promoters holding highest number of shares of

Key fundamentals

Evaluate the intrinsic value of Dr Lalchandani Labs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 16.1973 14.0242 12.9424 13.6059 14.527
Liabilities 16.1973 14.0242 12.9424 13.6059 14.527
Equity 8.6371 4.3331 4.3331 4.3331 4.3331
Gross Profit 0.0714 0.9233 0.1996 0.0834 2.406
Net Profit 0.0636 0.4172 0.6175 -1.5628 0.9333
Cash From Operating Activities -0.7646 0.3671 -0.218 -0.0013 2.0056
NPM(%) 1.51 9.36 12.83 -31 8.27
Revenue 4.1858 4.4538 4.8095 5.0402 11.2787
Expenses 4.1144 3.5305 4.6099 4.9568 8.8727
ROE(%) 0.44 2.94 4.36 -11.03 6.58

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dr Lalchandani Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 700.05 0.32 0.00 5.23 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 123.90 1.52 4070.00 19.07 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.49 0.23 0.00 39.60 -39.50 0.00
Astec Lifesciences Ltd 796.55 0.45 0.00 17.98 -363.14 0.00

Company Info

The Company was originally incorporated as partnership firm at New Delhi vide Partnership Agreement dated 15th Day of September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited incorporated under the provisions of Companies Act, 2013 vide certificate of Incorporation dated 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Corporate Identification Number of the Company is U85320DL2017PLC321605.MAJOR EVENTS AND MILESTONES2017- Incorporation of the Company in the name and style of "Dr Lalchandani Labs Limited" to takeover the Existing Partnership Firm.- Entered into an Agreement for takeover of the Existing partership Firm named on going concern basis Dr A Lalchandani Pathology Laborataries2018- Entered in to an Agreement for purchase of acquiring office premises at J-23, Block-J, Lajpat Nagar-III, New Delhi for consideration other than cash from promoter, Mr. Arjan Lal Chandani.

The Company was originally incorporated as partnership firm at New Delhi vide Partnership Agreement dated 15th Day of September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited incorporated under the provisions of Companies Act, 2013 vide certificate of Incorporation dated 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Corporate Identification Number of the Company is U85320DL2017PLC321605.MAJOR EVENTS AND MILESTONES2017- Incorporation of the Company in the name and style of "Dr Lalchandani Labs Limited" to takeover the Existing Partnership Firm.- Entered into an Agreement for takeover of the Existing partership Firm named on going concern basis Dr A Lalchandani Pathology Laborataries2018- Entered in to an Agreement for purchase of acquiring office premises at J-23, Block-J, Lajpat Nagar-III, New Delhi for consideration other than cash from promoter, Mr. Arjan Lal Chandani.

Read More

Parent Organisation

Dr. Lalchandani Labs Ltd.

Founded

02/08/2017

Managing Director

Dr.Arjan Lal Chandani

NSE Symbol

FAQ

The current price of Dr Lalchandani Labs Ltd is

The 52-week high for Dr Lalchandani Labs Ltd is

The market capitalization of Dr Lalchandani Labs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dr Lalchandani Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dr Lalchandani Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dr Lalchandani Labs Ltd shares.

The CEO of Dr Lalchandani Labs Ltd is Dr.Arjan Lal Chandani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT